Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chishala Chabala

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2018
Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVDeborah Ford, Rebecca Turner, Anna Turkova, et al.
Eclinicalmedicine|July 15, 2024
Development of tuberculosis treatment decision algorithms in children below 5 years hospitalised with severe acute malnutrition in Zambia and Uganda: a prospective diagnostic cohort studyChishala Chabala, Clémentine Roucher, Minh Huyen Ton Nu Nguyet, et al.
Eclinicalmedicine|April 28, 2025
Treatment decision algorithms for tuberculosis screening and diagnosis in children below 5 years hospitalised with severe acute malnutrition: a cost-effectiveness analysisMarc d'Elbée, Nyashadzaishe Mafirakureva, Chishala Chabala, et al.
The Pediatric Infectious Disease Journal|July 28, 2023
Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIVChishala Chabala, Anna Turkova, Monica Kapasa, et al.
Plos Medicine|November 21, 2023
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysisLufina Tsirizani Galileya, Roeland E Wasmann, Chishala Chabala, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2022
Population pharmacokinetics of ethambutol in African children: a pooled analysisTjokosela Tikiso, Helen McIlleron, Mahmoud Tareq Abdelwahab, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 TrialLisanne A H Bevers, Hylke Waalewijn, Alexander J Szubert, et al.
The Lancet. Infectious Diseases|November 9, 2012
Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive studyMatthew Bates, Justin O'Grady, Markus Maeurer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2024
Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE TrialChishala Chabala, Eric Wobudeya, Marieke M van der Zalm, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIVLufina Tsirizani, Hylke Waalewijn, Alexander Szubert, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2018
Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVDeborah Ford, Rebecca Turner, Anna Turkova, et al.
Eclinicalmedicine|July 15, 2024
Development of tuberculosis treatment decision algorithms in children below 5 years hospitalised with severe acute malnutrition in Zambia and Uganda: a prospective diagnostic cohort studyChishala Chabala, Clémentine Roucher, Minh Huyen Ton Nu Nguyet, et al.
Eclinicalmedicine|April 28, 2025
Treatment decision algorithms for tuberculosis screening and diagnosis in children below 5 years hospitalised with severe acute malnutrition: a cost-effectiveness analysisMarc d'Elbée, Nyashadzaishe Mafirakureva, Chishala Chabala, et al.
The Pediatric Infectious Disease Journal|July 28, 2023
Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIVChishala Chabala, Anna Turkova, Monica Kapasa, et al.
Plos Medicine|November 21, 2023
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysisLufina Tsirizani Galileya, Roeland E Wasmann, Chishala Chabala, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2022
Population pharmacokinetics of ethambutol in African children: a pooled analysisTjokosela Tikiso, Helen McIlleron, Mahmoud Tareq Abdelwahab, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 TrialLisanne A H Bevers, Hylke Waalewijn, Alexander J Szubert, et al.
The Lancet. Infectious Diseases|November 9, 2012
Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive studyMatthew Bates, Justin O'Grady, Markus Maeurer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2024
Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE TrialChishala Chabala, Eric Wobudeya, Marieke M van der Zalm, et al.
Antimicrobial Agents and Chemotherapy|September 26, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIVLufina Tsirizani, Hylke Waalewijn, Alexander Szubert, et al.
Pageof 5